Demant A/S : Solid finish – Outlook implies slight upside risk on top line
>Solid finish on top line – partially flagged already yesterday - Demant’s FY 2021 revenues of DKK 18,418m (+27.3% y-o-y) were 1%/0% vs ODDO BHF/consensus. Organic growth of 27% was slightly below our and the consensus’ expectations of 28%. Acquisitions contributed 100bp to growth, which was eaten up by forex headwind. Drivers of organic growth was a strong performance at Hearing aids and Hearing care with 34% organic growth, respectively. The Oticon More hearing aid ...William Demant Holding is a holding company. Through its subsidiaries, Co develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. Co. focuses on four areas: Hearing Devices, Diagnostic Instruments, Hearing Implants and Personal Communication. Co.'s hearing devices include Oticon, Bernafon, Sonic, Phonic Ear, and FrontRow. Co.'s Hearing implant consist of Oticon Medical. Co.'s diagnostic instruments include Maico, Interacoustics, Amplivox, Grason-Stadler, MedRx, and Micromedical. Co.'s personal communication consists of Sennheiser Communications.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.